IOVA

SetupConviction 77LongHealthcareScan · Thu, Sep 24, 2026

High tight flagInside barmomentum

Iovance Biotherapeutics, Inc. (IOVA) closed at $10.81 (+6.08%) on Sep 24, 2026. It is in the "Setting up" lane with a high tight flag pattern. Price is above its 50-day and above its 200-day moving average. RSI(14) 73, RS Rating 99, at a 52-week high, +329.0% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

IOVA$10.81+6.08%

ResistanceSupportVol 14

Vol MA14 14.85M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

WSB mentions · 24h changelatest -60.00%· 2 mentions

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Trade plan

LongReward : Risk1.30

Entry

10.98

Risk

Stop

10.10

-8.0% to stop

Reward

Target 1

12.13

+10.5% to target

Stretch

Target 2

13.28

+20.9% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

IOVANCE BIOTHERAPEUTICS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.iovance.com ↗

Price10.81

Change+6.08%

Gap+2.45%

Rel volume0.85×

Avg volume13.45M

Avg $ vol126M

SMA 209.16

SMA 507.29

SMA 2004.40

Price vs 50+48.35%

Price vs 200+145.64%

MA stackbullish

50/200 cross—

Supertrendup · 8.76

RSI (14)73

MACD hist0.07

MACD crossbull · 6d

Stoch %K / %D94 / 85

ADX (14)55

+DI / −DI38 / 8

RSI divergence—

MACD divergence—

ATR %5.44%

ADR %5.54%

52w high10.81

52w low1.81

From 52w high+0.00%

Above 52w low+497.24%

New 52w highYes

SqueezeOff

Bollinger width39.21%

%B0.96

Donchian pos94.88%

Donchian high10.98

Donchian low7.66

AVWAP (52w high)10.34

vs AVWAP high+4.55%

AVWAP (52w low)4.35

vs AVWAP low+148.68%

OBV trendUp

Chaikin MF (20)0.25

Today vs 20d0.85×

Avg vol (14d)14.85M

Avg vol (20d)13.45M

Avg $ vol (20d)126M

Market cap4.9B

RS Rating99 / 99

RS 3m (vs SPY)+152.28%

RS 6m (vs SPY)+171.45%

RS line new highYes

Trend template8/8

Technical rank99.0

1 week+7.88%

1 month+28.08%

3 months+156.77%

6 months+188.27%

1 year+422.22%

YTD+328.97%

P/E-12.52

P/B6.65

P/S18.58

P/FCF-14.56

EPS-1.09

Div yield—

ROE-53.12%

ROA-42.71%

Debt/Eq—

Current4.34

EV/EBITDA-12.26

Gross margin—

Net margin-148.38%

Rev growth60.60%

EPS growth-5.05%

Price target10.13

Target upside-6.29%

Analyst ratingBuy

Institutional69.95%

Ent. value4.79B

Revenue99.31M

Net income-47.31M

Gross profit—

Free cash flow-336.24M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out446.5M

Employees975

ListedWed, May 26, 2010

Free float372.08M

Float %90.3%

Short interest88.14M

Days to cover5.3d

Short volume42.4%

Squeeze score67 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.11 vs −$0.17

Last surprise+35.3% beat

Setup gradeA

Conviction77 / 100

Pattern quality69%

Tech rank99.0 / 100

Group rank59 / 100

Status laneSetting up

Setup directionLong

Pattern familyMomentum

Resistance10.98

Support9.83

Days since event—

Candle confirmInside bar

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IOVA

All disclosures →

No recent disclosed trades by Congress in IOVA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IOVA

Insider	Side	Shares	Value	Traded	Filed
Kirby Daniel Gordon Chief Commercial Officer · Common Stock · 2026-08-10	Exercise	10K	—	2026-08-10	2026-08-12
Kirby Daniel Gordon Chief Commercial Officer · Common Stock · 2026-08-10	Tax	2.44K	$16K	2026-08-10	2026-08-12
Kirby Daniel Gordon Chief Commercial Officer · Restricted Stock Units · 2026-08-10	Exercise	10K	—	2026-08-10	2026-08-12
Roche Corleen M. Chief Financial Officer · Common Stock · 2026-08-06	Exercise	49.99K	—	2026-08-06	2026-08-10
Roche Corleen M. Chief Financial Officer · Common Stock · 2026-08-06	Tax	21.24K	$132K	2026-08-06	2026-08-10
Roche Corleen M. Chief Financial Officer · Restricted Stock Units · 2026-08-06	Exercise	49.99K	—	2026-08-06	2026-08-10
Countouriotis Athena Director · Deferred Restricted Stock Unit · 2026-06-16	Grant	90.32K	—	2026-06-16	2026-06-18
Dukes Iain D. Director · Deferred Restricted Stock Unit · 2026-06-16	Grant	180.63K	—	2026-06-16	2026-06-18
Puri Raj K. Chief Regulatory Officer · Restricted Stock Units · 2026-06-16	Grant	15K	—	2026-06-16	2026-06-18
Maynard Ryan D Director · Deferred Restricted Stock Unit · 2026-06-16	Grant	90.32K	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in IOVA · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.